Connect with us

Health

Novel cancer-fighting gene therapy enters phase I clinical trial – News-Medical.Net

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize…

Published

on

Article feature image

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells. The safety of the novel therapy is now being tested on patients with bone marrow cancer in a phase I clinical trial.
A new cancer-fighting gene therapy has been applied in the clinic for the first time after 20 years of preliminary research in the laboratories of the Max Delbrück Center for Molecular Medicine in the…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending